MARKET EYE-Cipla gains on partner's contract win

Fri Nov 30, 2012 10:45am IST

Related Topics

Stocks

   

* Shares in drugmaker Cipla rise 1.4 percent after
Cipla Medpro won a share in South Africa's $667 million
contract, as it supplies the bulk of Cipla Medpro's drugs.
* Dealers say the company may garner revenues of $30-40 million
from Cipla Medpro's contract.
* South Africa on Thursday awarded a $667 million contract to
supply life-prolonging HIV medicine to 12 international and
domestic firms, including Cipla Medpro, to deal with its biggest
health problem. 
* Cipla also plans to offer $215 million for a majority stake in
South Africa's Cipla Medpro to strengthen its presence in
Africa's fast-growing market for cheap, generic versions of
branded drugs. 

 (abhishek.vishnoi@thomsonreuters.com /;
abhishek.vishnoi.reuters.com@reuters.net)
FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

REUTERS SHOWCASE

Earnings Season

Earnings Season

Reliance Q4 sales rise, refining margin narrows.  Read 

Innovative Solution

Innovative Solution

Turning smog into jewels - a Dutch designer's solution to Beijing's pollution.  Video 

Insider Trading

Insider Trading

Rajaratnam's brother loses bid to dismiss insider trading charges.  Full Article 

Literary Giant Dies

Literary Giant Dies

Mourning and memories in Gabriel Garcia Marquez's languid hometown.  Full Article 

S&P on India

S&P on India

S&P: India's ratings to depend on next govt econ, fiscal policies.  Full Article 

Ambitious Aim

Ambitious Aim

In green car race, Toyota adds muscle with fuel-cell launch.  Full Article 

Bond Market

Bond Market

A star abroad, RBI boss riles bond traders at home  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage